NSD3 drives progression of multiple cancers, mainly through the NSD3–BRD4–Chromodomain-helicase-DNA-binding protein 8(CHD8) axis and the BRD4–NSD3–MYC axis, and is closely associated with poor overall survival and progression-free survival of cancer patients [123,124,125]. This evidence concerns the gene MYC and cancer.